Andromeda Biotech in Talks on Sale to U.S. Drug Company

Announcement comes two days after Teva Pharmaceutical Industries sold back its stake in the drug firm and its flagship diabetes treatment.

Reuters
Shelly Appelberg
Send in e-mailSend in e-mail
Reuters
Shelly Appelberg

Comments